ACAun Yeong Chong

Aun Yeong Chong

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Aun Yeong Chong has a total of 115 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    A Woman’s Heart: The Microvascular Disease Dilemma

    by Laurie-Anne Boivin-Proulx, Derek Y.F. So, Heather Tulloch, Jodi Heshka, Lisa-Marie Maukel, Chiara Licandro, Zeeshan Ahmed, Elizabeth D. Chan, Zandra Koopman, Kerri-Anne Mullen, et al.

    • 1 May 2026
      • Vol. 42  (5S) , S35-S45

    A Woman's Heart: The Microvascular Disease Dilemma.

    by Laurie-Anne Boivin-Proulx, Derek Y F So, Heather Tulloch, Jodi Heshka, Lisa-Marie Maukel, Chiara Licandro, Zeeshan Ahmed, Elizabeth D Chan, Zandra Koopman, Kerri-Anne Mullen, et al.

    Coronary microvascular and vasomotor dysfunction (CMVD) is not a novel entity, and it disproportionally affects more women than men presenting with cardiac symptoms in the setting of nonobstructive coronary artery disease. Recent advances in the development and validation of diagnostic tools have brought CMVD into sharper focus, driving renewed interest and momentum in cardiovascular research within this field. In this review, we summarize current understanding of CMVD pathophysiology, discuss available diagnostic modalities and their limitations, and review contemporary management strategies, with particular emphasis on the multidisciplinary contributions of allied health professionals and the role of patient-support groups. Importantly, we emphasize the recognition of sex-specific differences in the prevalence, underlying mechanisms, symptom burden, and prognosis of CMVD as a clinical and research priority, as it provides the biological and clinical rationale for sex-specific diagnostic strategies and more personalized management and therapeutic approaches. Finally, we also discuss our perspective on how different organizations can help promote the awareness and research to enhance our ability to diagnose and treat this condition in future.

  • Global Microvascular Dysfunction and Incomplete Recovery in Takotsubo Syndrome: Insights From Serial PET Imaging

    by Yoshito Kadoya, Aun Yeong Chong, Gary R. Small, Benjamin J.W. Chow, Robert A. Dekemp, Terrence D. Ruddy, Rob S. Beanlands, Andrew M. Crean

    BACKGROUND: The proposed cause of Takotsubo syndrome (TTS) includes coronary microvascular dysfunction. This study aimed to investigate coronary microvascular dysfunction and its recovery in patients with TTS using serial positron emission tomography myocardial perfusion imaging. METHODS: Patients with TTS who underwent cardiac positron emission tomography within 30 days of admission and at 6-month follow-up (May 2017–June 2023) were analyzed. Changes in positron emission tomography parameters, including extent of myocardial perfusion abnormality, left ventricular function, rest and stress myocardial blood flow (MBF), myocardial flow reserve, and coronary vascular resistance (CVR), were assessed from baseline to follow-up. In apical TTS, segmental analyses (basal, mid, distal segments, and apex) and intersegment differences were evaluated. RESULTS: Of 130 patients screened, 62 patients (median age, 70 years, 97% women) were included. After a median follow-up of 178 (121–282) days, global rest and stress MBF, myocardial flow reserve, and CVR significantly improved at follow-up (0.81–0.89 mL/min per gram, P =0.004; 1.56–2.61 mL/min per gram, P P P P <0.001), including the basal segment; however, persistent MBF and CVR abnormalities were identified in the distal segment and apex, despite full recovery of left ventricular function. CONCLUSIONS: Patients who underwent serial positron emission tomography perfusion imaging for TTS demonstrated reversible reductions in rest and stress MBF, myocardial flow reserve, and increases in CVR, suggestive of TTS-related coronary microvascular dysfunction and subsequent subtotal recovery. Coronary microvascular dysfunction extended beyond regions of wall motion abnormalities, and regional coronary flow abnormalities persisted in the medium term even after recovery of left ventricular function.


  • Clinical Deployment of Real-Time Left Ventricular Ejection Fraction Estimation from Coronary Angiography

    by Pascal Thériault-Lauzier, Nils Perrin, Arash Sarshoghi, Stella Ly, Michael Knafo, Aurélie Grandchamp, Yan Xu Rong, Marie-Gabrielle Lessard, Denis Corbin, Bahareh Taji, et al.


  • Open Access

    Patient decision aids for aortic stenosis and chronic coronary artery disease: a systematic review and meta-analysis

    by Emma Harris, Alex Benham, John Stephenson, Dwayne Conway, Aun-Yeong Chong, Helen Curtis, Felicity Astin

    Aims: Shared decision-making is recommended for patients considering treatment options for severe aortic stenosis (AS) and chronic coronary artery disease (CAD). This review aims to systematically identify and assess patient decision aids (PtDAs) for chronic CAD and AS and evaluate the international evidence on their effectiveness for improving the quality of decision-making. Methods and results: Five databases (Cochrane, CINAHL, Embase, MEDLINE, and PsycInfo), clinical trial registers, and 30 PtDA repositories/websites were searched from 2006 to March 2023. Screening, data extraction, and quality assessments were completed independently by multiple reviewers. Meta-analyses were conducted using Stata statistical software. Eleven AS and 10 CAD PtDAs were identified; seven were less than 5 years old. Over half of the PtDAs were web based and the remainder paper based. One AS and two CAD PtDAs fully/partially achieved international PtDA quality criteria. Ten studies were included in the review; four reported on the development/evaluation of AS PtDAs and six on CAD PtDAs. Most studies were conducted in the USA with White, well-educated, English-speaking participants. No studies fulfilled all quality criteria for reporting PtDA development and evaluation. Meta-analyses found that PtDAs significantly increased patient knowledge compared with ‘usual care’ (mean difference: 0.620; 95% confidence interval 0.396–0.845, P < 0.001) but did not change decisional conflict. Conclusion: Patients who use PtDAs when considering treatments for AS or chronic CAD are likely to be better informed than those who do not. Existing PtDAs may not meet the needs of people with low health literacy levels as they are rarely involved in their development. Registration: PROSPERO: CRD42021264700.


  • Utility of FFRCT in Patients with Chest Pain

    by Anahita Tavoosi, Yoshito Kadoya, Aun Yeong Chong, Gary R. Small, Benjamin J. W. Chow

    Purpose of Review The goal of this article is to review the data supporting the use of fractional flow reserve derived from coronary computed tomography angiography (FFRCT) in patients with chest pain. Review Findings Numerous clinical trials have demonstrated that the diagnostic accuracy of coronary computed tomography angiography (CCTA) can be improved with the use of FFRCT, primarily due to its superior specificity when compared to CCTA alone. This promising development may help reduce the need for invasive angiography in patients presenting with chest pain. Furthermore, some studies have indicated that incorporating FFRCT into decision-making is safe, with an FFRCT value of ≥ 0.8 being associated with favorable outcomes. While FFRCT has been shown to be feasible in patients with acute chest pain, further large-scale studies are warranted to confirm its utility. Summary The emergence of FFRCT as a tool for the management of patients with chest pain is promising. However, potential limitations require the interpretation of FFRCT in conjunction with clinical context.


  • Fibrotic Plaque and Microvascular Dysfunction Predict Early Cardiac Allograft Vasculopathy Progression After Heart Transplantation: The Early Post Transplant Cardiac Allograft Vasculopathy Study

    by Sharon Chih, Aun Yeong Chong, Vladimír Džavík, Derek Y. So, Natasha Aleksova, George A. Wells, Jordan Bernick, Christopher B. Overgaard, Ellamae Stadnick, Lisa M. Mielniczuk, et al.

    Background: Early cardiac allograft vasculopathy (CAV) prognostication is needed to improve long-term outcomes after heart transplantation. We characterized first year posttransplant coronary anatomic-physiologic alterations to determine predictors of early CAV progression.Methods: Heart transplant recipients at 2 institutions (enrolled January 2018 to March 2021) underwent prospective evaluation 3 and 12-month posttransplant with angiography and left anterior descending artery intravascular ultrasound, optical coherence tomography, fractional flow reserve, coronary flow reserve, and index of microcirculatory resistance measurements. CAV progression was assessed by intravascular ultrasound change in percentage intimal volume from baseline to 12-month follow-up.Results: Eighty-two patients (mean age, 51 years; 60% men) completed evaluation at mean 13.8 and 56.3 weeks posttransplant. Donor atherosclerosis (baseline intravascular ultrasound maximal intimal thickness, = 0.5 mm) was evident in 50%. De novo (follow-up maximal intimal thickness, = 0.5 mm) and rapidly progressive CAV (maximal intimal thickness, = 0.5-mm increase from baseline) developed in 24% and 13%, respectively. On optical coherence tomography, baseline to follow-up median intimal volume increased 42% (0.58 mm(3)/mm), percentage intimal volume increased 44% (4.6%), vessel volume decreased 4% (-0.50 mm(3)/mm) and lumen volume decreased 9% (-1.02 mm(3)/mm); P<0.05 for all. Fibrotic plaque was the predominant morphology: baseline, 29% and follow-up, 50%. Coronary physiology was abnormal in 41% at baseline and 45% at follow-up, with 1 in 5 patients having microvascular dysfunction (index of microcirculatory resistance, = 25). On multivariable linear regression analysis, recipient male sex, fibrotic plaque, and index of microcirculatory resistance were independent predictors of coronary disease progression.Conclusions: Fibrotic plaque on optical coherence tomography and index of microcirculatory resistance early posttransplant predict CAV progression in the first year of transplantation.Registration:URL: ; Unique identifier: NCT03217786.


  • Open Access

    Platelet Quiescence in Patients With Acute Coronary Syndrome Undergoing Coronary Artery Bypass Graft Surgery

    by Kiran Sarathy, George A. Wells, Kuljit Singh, Etienne Couture, Aun Yeong Chong, Fraser Rubens, Marie Lordkipanidzé, Jean‐François Tanguay, Derek So

    Background: The optimal antiplatelet strategy for patients with acute coronary syndromes who require coronary artery bypass surgery remains unclear. While a more potent antiplatelet regimen will predispose to perioperative bleeding, it is hypothesized that through “platelet quiescence,” ischemic protection conferred by such therapy may provide a net clinical benefit. Methods and Results: We compared patients undergoing coronary artery bypass surgery who were treated with a more potent antiplatelet inhibition strategy with those with a less potent inhibition through a meta‐analysis. The primary outcome was all‐cause mortality after bypass surgery. The analysis identified 4 studies in which the antiplatelet regimen was randomized and 6 studies that were nonrandomized. Combining all studies, there was an overall higher mortality with weaker strategies compared with more potent strategies (odds ratio, 1.38; 95% CI, 1.03–1.85; P =0.03). Conclusions: Our findings support the concept of platelet quiescence, in reducing mortality for patients with acute coronary syndrome requiring coronary artery bypass surgery. This suggests the routine up‐front use of potent antiplatelet regimens in acute coronary syndrome, irrespective of likelihood of coronary artery bypass graft.


  • Transradial Versus Transfemoral Access for Percutaneous Coronary Intervention in ST-Segment–Elevation Myocardial Infarction

    by Pietro Di Santo, Trevor Simard, George A. Wells, Richard G. Jung, F. Daniel Ramirez, Paul Boland, Jeffrey A. Marbach, Simon Parlow, Kwadwo Kyeremanteng, Doug Coyle, et al.

    Background: Transradial access (TRA) has emerged as the preferred vascular access site for coronary angiography and percutaneous coronary intervention. This systematic review and meta-analysis was performed to evaluate 30-day all-cause mortality comparing TRA with transfemoral access for percutaneous coronary intervention in patients with ST-segment–elevation myocardial infarction. Methods: We performed a systematic literature search and meta-analysis of randomized controlled studies published from inception until January 7, 2020, in MEDLINE, EMBASE, Cochrane Central Register of Controlled Trials, and Web of Science Core Collection. Preferred Reported Items for Systematic Reviews and Meta-Analyses guidelines were used for abstracting data. The primary outcome was all-cause mortality at 30 days. Secondary outcomes included myocardial infarction, major bleeding, stroke, and access site complications. Results: A total of 14 studies representing 11 707 patients (5802 patients with TRA; 5905 patients with transfemoral access) were included in this systematic review. All-cause mortality (N=8 studies) was significantly reduced in the TRA group with an overall risk ratio (RR) of 0.72 (95% CI, 0.56–0.92) in the pooled analysis. Major bleeding (N=12 studies; RR, 0.60 [95% CI, 0.45–0.80]) and access site complications (N=9 studies; RR, 0.40 [95% CI, 0.30–0.53]) were significantly higher in the transfemoral access group. There was no statistical difference in reinfarction (N=10 studies; RR, 0.96 [95% CI, 0.75–1.25]) or stroke (N=8 studies; RR, 1.47 [95% CI, 0.87–2.50]). Conclusions: TRA is associated with lower 30-day mortality, major bleeding, and access site complications when compared with transfemoral access in ST-segment–elevation myocardial infarction patients who undergo percutaneous coronary intervention. Registration: URL: https://www.crd.york.ac.uk/PROSPERO/ ; Unique identifier: 127955.